Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) has issued an update.
Dawnrays Pharmaceutical Holdings Ltd. has announced the appointment of Mr. Hu Shuo as a non-executive director, effective August 1, 2025. Mr. Hu brings over 20 years of experience in equity investment and mergers and acquisitions, which could enhance the company’s strategic capabilities and strengthen its market position. His appointment is part of the company’s ongoing efforts to bolster its governance and leadership structure.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 2,157,732
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.13B
For a thorough assessment of 2348 stock, go to TipRanks’ Stock Analysis page.